Martingale Asset Management’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-864
| Closed | -$447K | – | 888 |
|
|
2020
Q3 | $447K | Sell |
864
-125
| -13% | -$64.7K | 0.01% | 839 |
|
|
2020
Q2 | $448K | Hold |
989
| – | – | 0.01% | 896 |
|
|
2020
Q1 | $348K | Sell |
989
-300
| -23% | -$106K | ﹤0.01% | 866 |
|
|
2019
Q4 | $478K | Hold |
1,289
| – | – | ﹤0.01% | 872 |
|
|
2019
Q3 | $429K | Hold |
1,289
| – | – | ﹤0.01% | 898 |
|
|
2019
Q2 | $404K | Hold |
1,289
| – | – | ﹤0.01% | 919 |
|
|
2019
Q1 | $395K | Hold |
1,289
| – | – | ﹤0.01% | 914 |
|
|
2018
Q4 | $300K | Buy |
+1,289
| New | +$300K | ﹤0.01% | 917 |
|
|
2017
Q1 | – | Sell |
-2,058
| Closed | -$376K | – | 936 |
|
|
2016
Q4 | $376K | Sell |
2,058
-68,934
| -97% | -$12.6M | 0.01% | 868 |
|
|
2016
Q3 | $11.6M | Sell |
70,992
-27,995
| -28% | -$4.59M | 0.17% | 163 |
|
|
2016
Q2 | $14.2M | Buy |
98,987
+2,895
| +3% | +$414K | 0.23% | 142 |
|
|
2016
Q1 | $13.1M | Buy |
96,092
+19,551
| +26% | +$2.67M | 0.26% | 138 |
|
|
2015
Q4 | $10.6M | Buy |
76,541
+6,500
| +9% | +$901K | 0.24% | 156 |
|
|
2015
Q3 | $9.41M | Buy |
70,041
+22,301
| +47% | +$3M | 0.23% | 148 |
|
|
2015
Q2 | $7.19M | Buy |
47,740
+610
| +1% | +$91.9K | 0.17% | 184 |
|
|
2015
Q1 | $6.37M | Sell |
47,130
-22,798
| -33% | -$3.08M | 0.15% | 203 |
|
|
2014
Q4 | $8.43M | Buy |
69,928
+55,720
| +392% | +$6.72M | 0.23% | 135 |
|
|
2014
Q3 | $1.61M | Buy |
14,208
+2,310
| +19% | +$262K | 0.05% | 343 |
|
|
2014
Q2 | $1.43M | Buy |
11,898
+2,100
| +21% | +$252K | 0.04% | 396 |
|
|
2014
Q1 | $1.26M | Buy |
9,798
+1
| +0% | +$128 | 0.04% | 412 |
|
|
2013
Q4 | $1.21M | Buy |
9,797
+2,100
| +27% | +$260K | 0.04% | 463 |
|
|
2013
Q3 | $905K | Sell |
7,697
-2,002
| -21% | -$235K | 0.03% | 557 |
|
|
2013
Q2 | $1.09M | Buy |
+9,699
| New | +$1.09M | 0.04% | 447 |
|